Healthcare

Overview: This is sessions provides current updates and information on the fast developing environment around the Coronavirus in the workplace. The circumstances surrounding the coronavirus are continuing to develop each day, and with the rapid-fire nature of the modern media, details vary from broadcast to broadcast, leaving the audience in fear and confused as to what next steps they should take. Having a plan is the best course of action, and with the changing national condition, employers are feeling the pressure of growing concern.

A widespread infectious disease outbreak like COVID-19 stresses the health care system. HIPAA Rules regarding protected health information (PHI) are not suspended, but key provisions in the Privacy Rule manage the permitted and required uses and disclosures of PHI. And, if there is a Presidential Declaration of a Public Health Emergency, the Secretary of the U.S. Department of Health and Human Services can temporarily waive some HIPAA requirements.

Overview: HIPAA Compliance has recently seen big changes in how the rules are enforced for individual access requests, long-overdue changes may be coming to regulations on Accounting of Disclosures of Protected Health Information (PHI), we can expect new rules regarding the HIPAA Notice of Privacy Practices and calling patients' cell phones, and a little-used HIPAA right may become a hot topic if the Affordable Care Act is threatened.

Overview: Under the Social Security Act, reimbursement for telehealth under Medicare has been subject to stringent restrictions. Only patients in certain identified practice settings in rural, physician-underserved areas were eligible. Care into the patient's home was not covered.

Overview: Mr. Wolfe will discuss best practices for structuring and evaluating new compensation models. His presentation will also focus on regulatory requirements, key provisions, valuation considerations and potential pitfalls that should be avoided when designing a new model. Why you should Attend: Today health care organizations are focused on developing compensation models that will position their physician enterprise for success. When health care organizations design a new compensation model, they must make sure the model complies with the Stark Law. This webinar will discuss how to perform this analysis. It will also discuss the potential impact that changes to the Stark Law may have if they are introduced by the government later this year. https://www.mentorhealth.com/webinar/-801977LIVE?channel=trainingregistry-May_2020_SEO

Overview: Many people work with various aspects of healthcare coding and billing but may not understand how providers generate their claim data, how they report the data to payors, and how payors use that information to reimburse providers. This webinar provides a high-level overview of all major aspects of healthcare coding, billing, and reimbursement.

Overview: For much of healthcare, HIPAA sets the standards for how to manage uses and disclosures of patient information, known as Protected Health Information (PHI). But when it comes to information related to the treatment of substance use disorders, regulations of the Substance Abuse and Mental Health Services Administration (SAMHSA) under 42 CFR Part 2 prevail, including rigorous controls on the release and re-release of patient information.

Overview: This course will cover the proper methodologies on conducting a HIPAA Risk Assessment based on the formula used by Federal auditors and via the guidelines of the NIST (National Institute of Standard for Technologies). The course will also cover the most important aspects to be aware of in terms of the Federal auditing process as well as the new risks regarding patients suing for wrongful disclosures. Why you should Attend: Have your done a HIPAA Risk Assessment? Do you know a risk assessment is the first thing the Feds will ask for in an audit? Is your risk assessment adequate? Do you have written policies in place for every single one of the implementation specification of the HIPAA Security Rule (even ones that don't apply) - do you know this is required!!

Overview: This lesson will be addressing how practice/business managers (or compliance offers) need to get their HIPAA house in order as HIPAA is now fully enforced and the government is not using kid gloves any more. It will also address major changes under the Omnibus Rule and any other applicable updates for 2020 and beyond. There are an enormous amount of issues and risks for covered entities and business associates these days. I will speak on specific experiences from over 17 years of experience in working as an outsourced compliance auditor, expert witness on HIPAA cases, and thoroughly explain how patients are now able to get cash remedies for wrongful disclosures of private health information. More importantly I will show you how to limit those risks by simply taking proactive steps and utilizing best practices. https://www.mentorhealth.com/webinar/--801981LIVE?channel=trainingregistry-May_2020_SEO

The impact of Data Integrity issues on a regulated company can be significant: it can result in recalls of products, warning or untitled letters, import alerts, injunctions, seizures, legal action, etc. These regulatory actions can have significant financial impact to the company. However, and most importantly, Data Integrity issues can lead to potential patient harm!! To ensure Data Integrity, a GxP regulated company needs to abide by principles, current regulations and industry best practices on the expectations for the management GxP regulated records and data. These principles, regulations and best practices, ensure that data is complete, consistent, accurate, secure and available throughout the record life cycle. This approach is intended to encourage innovation and technological advances while avoiding unacceptable risk to product quality, patient safety and public health.

LEARNING OBJECTIVES • Understand human error: factors and root causes. • Understand the importance of human error reduction: regulatory and business. • Define the process to manage Human Error deviations. • Identify root causes associated to human error deviations. • Learn how to measure human error rates at your site. • Identify how to control human error and what I can do to support human reliability. WHO WILL BENEFIT • Training managers and coordinators • Operations • Manufacturing • Plant engineering • QA/QC staff • Process excellence/improvement professionals • Industrial/process engineers • Compliance officers • Regulatory/legislative affairs professionals • General/corporate counsel Use Promo Code SPRS20 and get flat 20% discount on all purchases. To Register (or) for more details please click on this below link: http://bit.ly/2TeStAa Email: support@trainingdoyens.com Toll Free: +1-888-300-8494 Tel: +1-720-996-1616 Fax: +1-888-909-1882

Overview: Classically, the law reasons by analogy, and from precedent. The theory is that the law should deal with like situations in like ways. Classically, the law reasons by analogy, and from precedent. The theory is that the law should deal with like situations in like ways. In some respects, however, Artificial Intelligence, especially the concept of machine learning, is virtually unprecedented, so the law is struggling with how to deal with it, or will be soon. Consider a few of the difficulties that the law will probably need to address: Who will pay for healthcare services dependent on AI, and who will be entitled to such payments? Will those payments be keyed to "value," the currently orthodox yardstick? If so, by what means will “value” be measured, especially if, as many predict, outcomes may change unforeseeably?

Overview: This lesson is going to get back to the basics using multiple real life scenarios and "what if's". My goal is to make this very confusing and not well explained law easy to understand for the typical staff member.

Overview: Healthcare professionals bear witness to human suffering on a routine basis and are constantly reminded that tragedy, pain, and challenge often loom large in the midst of helping patients heal. As a result, compassion fatigue and burnout are major hazards of the profession that are becoming far too common. This webinar focuses on understanding each of these challenges, their similarities and differences. In addition to defining and comparing these conditions, specific triggers will be explored. Participants will gain awareness of key signs and symptoms of compassion fatigue and burnout, while learning how to manage stressors and their consequences. Specific attention will be given to physical, emotional/mental and behavioral symptoms. Awareness training is a key component to the training. Underlying beliefs about compassion fatigue are explored and other general signs and symptoms of burnout are explained.

Overview: Healthcare professionals bear witness to human suffering on a routine basis and are constantly reminded that tragedy, pain, and challenge often loom large in the midst of helping patients heal. As a result, compassion fatigue and burnout are major hazards of the profession that are becoming far too common. This webinar focuses on understanding each of these challenges, their similarities and differences. In addition to defining and comparing these conditions, specific triggers will be explored. Participants will gain awareness of key signs and symptoms of compassion fatigue and burnout, while learning how to manage stressors and their consequences. Specific attention will be given to physical, emotional/mental and behavioral symptoms. Awareness training is a key component to the training. Underlying beliefs about compassion fatigue are explored and other general signs and symptoms of burnout are explained.

With all new events the FDA has stated that it “recognizes the significant public interest in cannabis and cannabis-derived compounds, particularly CBD.” However, there are many unanswered questions about the science, safety, and quality of products containing CBD. AREAS COVERED • Current events associated to cannabis • FDA, CANADA, and Europe regulations and standards • What does it mean for drug manufacturing sites? • Application from Pharma to Cannabis • Our role from GMP standpoint • Industry crossover WHO WILL BENEFIT • Training managers and coordinators • Operations • Manufacturing • Plant engineering • QA/QC staff • Process excellence/improvement professionals • Industrial/process engineers • Compliance officers • Regulatory/legislative affairs professionals • General/corporate counsel To Register http://bit.ly/2RRxuBu Email: support@trainingdoyens.com Toll Free: +1-888-300-8494 Tel: +1-720-996-1616 Fax: +1-888-909-1882

Importing FDA regulated products requires careful planning before you even start. Registration, product compliance, record and data submission must be exactly correct or your product will be detained. Likewise, the U.S. Customs and Border Protection (CBP) must be precise or your entry is not going anywhere. Some mistakes are common, others reflect a lack of understanding of how FDA and Customs and Border Protection (CBP) operate a joint program.

This virtual seminar will address those project management critical tasks within each project phase that must be performed flawlessly for effective project execution to occur and will provide the foundation and direction for future study of the subject.

Importing FDA regulated products requires careful planning before you even start. Registration, product compliance, record and data submission must be exactly correct or your product will be detained. Likewise, the U.S. Customs and Border Protection (CBP) must be precise or your entry is not going anywhere. Some mistakes are common, others reflect a lack of understanding of how FDA and Customs and Border Protection (CBP) operate a joint program. The logistics of importing products complicates the process further and you must know the consequences of your decisions. Some problems can cost you time and money, especially when you do not work promptly with the FDA. If you end up with having your entry "refused." There is no appeal. Then you face the possibility of additional steep fines by CBP and be blocked from the U.S. market.

This webinar will guide healthcare professionals, health IT vendors, and insurance companies to maintain information security and patient confidentiality. Also, an overview of a comparative analysis will be presented, comparing SAMHSA to the HIPAA laws relating to protected health information in general.